5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
摘要:
A series of 1, 5-disubstituted hydantoins, whose structure was designed to interact at the ATP binding site of EGFR, was synthesized and evaluated for inhibition of EGFR kinase activity and antiproliferative action. Some of these compounds, characterized by a 1-phenethyl and a 5-(E)-benzylidene substituent, inhibited EGFR autophosphorylation and polyGAT phosphorylation, and also inhibited the growth and proliferation of human A431 cells, which overexpress EGFR. These compounds can therefore be regarded as examples of a new scaffold for tyrosine kinase inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
5-Benzylidene-hydantoins: Synthesis and antiproliferative activity on A549 lung cancer cell line
作者:Valentina Zuliani、Caterina Carmi、Mirko Rivara、Marco Fantini、Alessio Lodola、Federica Vacondio、Fabrizio Bordi、Pier Vincenzo Plazzi、Andrea Cavazzoni、Maricla Galetti、Roberta R. Alfieri、Pier Giorgio Petronini、Marco Mor
DOI:10.1016/j.ejmech.2009.01.035
日期:2009.9
substituents, was found to be the most active derivative of the series. It inhibited EGFR autophosphorylation and induced DNA damage in A549 cells. Compound 7 and other synthesized 5-benzylidene hydantoin derivatives increased p53 levels, suggesting that the dual mechanism of action was a common feature shared by compound 7 and other member of the series.
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
作者:Caterina Carmi、Andrea Cavazzoni、Valentina Zuliani、Alessio Lodola、Fabrizio Bordi、Pier Vincenzo Plazzi、Roberta R. Alfieri、Pier Giorgio Petronini、Marco Mor
DOI:10.1016/j.bmcl.2006.05.010
日期:2006.8
A series of 1, 5-disubstituted hydantoins, whose structure was designed to interact at the ATP binding site of EGFR, was synthesized and evaluated for inhibition of EGFR kinase activity and antiproliferative action. Some of these compounds, characterized by a 1-phenethyl and a 5-(E)-benzylidene substituent, inhibited EGFR autophosphorylation and polyGAT phosphorylation, and also inhibited the growth and proliferation of human A431 cells, which overexpress EGFR. These compounds can therefore be regarded as examples of a new scaffold for tyrosine kinase inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.